Crafting concise and authoritative healthcare resources

Discover how S. Karger has positioned itself as a reference in the healthcare industry by publishing trusted content for 30 years.

After multiple clinical trial failures, FibroGen lays off one-third of staff

FibroGen is laying off 104 employees in the US, it disclosed in an SEC filing Wednesday morning. That equates to 32% of its workforce, the

July 20, 2023

How safe are GLP-1R agonists in early pregnancy?

JAMA Internal Medicine study examines the safety of GLP-1 receptor agonists and other second-line antidiabetic medications during early pregnancy, finding no significant increase in congenital

December 14, 2023

Paclitaxel albumin bound by Bristol-Myers Squibb for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

April 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.